摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-1-(3,5-dimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene | 89946-15-6

中文名称
——
中文别名
——
英文名称
trans-1-(3,5-dimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene
英文别名
trans-3,4,5,3',5'-pentamethoxystilbene;3,5,3',4',5'-pentamethoxystilbene;3,3',4,5,5'-pentamethoxystilbene;(trans)-5-(3,5-Dimethoxystyryl)-1,2,3-trimethoxybenzene;5-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]-1,2,3-trimethoxybenzene
trans-1-(3,5-dimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene化学式
CAS
89946-15-6
化学式
C19H22O5
mdl
——
分子量
330.381
InChiKey
PYSIIZCKWCWZPP-VOTSOKGWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136-138 °C
  • 沸点:
    474.0±40.0 °C(Predicted)
  • 密度:
    1.128±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    46.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    trans-1-(3,5-dimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene 在 palladium on activated charcoal 氢气 作用下, 以 乙酸乙酯 为溶剂, 反应 4.0h, 生成 5-[2-(3,5-二甲氧基苯基)乙基]-1,2,3-三甲氧基苯
    参考文献:
    名称:
    Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization
    摘要:
    An array of cis-, trans-, and dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in the five cancer cell cultures A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, and MLM melanoma. Several cis-stilbenes, structurally similar to combretastatins, were highly cytotoxic in all five cell lines and these were also found to be active as inhibitors of tubulin polymerization. The most active compounds also inhibited the binding of colchicine to tubulin. The most potent of the new compounds, both as a tubulin polymerization inhibitor and as a cytotoxic agent, was (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (5a). This substance was almost as potent as combretastatin A-4 (1a), the most active of the combretastatins, as a tubulin polymerization inhibitor. Compound 5a was found to be approximately 140 times more cytotoxic against HT-29 colon adenocarcinoma cells and about 10 times more cytotoxic against MCF-7 breast carcinoma cells than combretastatin A-4. However, 5a was found to be about 20 times less cytotoxic against A-549 lung carcinoma cells, 30 times less cytotoxic against SKMEL-5 melanoma cells, and 7 times less cytotoxic against MLM melanoma cells than combretastatin A-4. The relative potencies 5a > 8a > 6a for the cis, dihydro, and trans compounds, respectively, as inhibitors of tubulin polymerization are in agreement with the relative potencies previously observed for combretastatin A-4 (1a), dihydrocombretastatin A-4 (1c), and trans-combretastatin A-4 (1b). The relative potencies 5a > 8a > 6a were also reflected in the results of the cytotoxicity assays. Structure-activity relationships of this group of compounds are also discussed.
    DOI:
    10.1021/jm00112a036
  • 作为产物:
    参考文献:
    名称:
    Design, Synthesis, and Discovery of Novel trans-Stilbene Analogues as Potent and Selective Human Cytochrome P450 1B1 Inhibitors
    摘要:
    A series of trans-stilbene derivatives containing a 3,5-dimethoxyphenyl moiety were prepared through a new efficient solution phase synthetic pathway, and their inhibitory activities were evaluated on human cytochrome P450s (CYP) 1A1, 1A2, and 1B1 to find a potent and selective CYP1B1 inhibitor. We found that a substituent at the 2-position of the stilbene skeleton plays a very important role in discriminating between CYP1As and CYP1B1. Among the compounds tested, the most selective and potent CYP1B1 inhibitor was 2,3',4,5'-tetramethoxystilbene, Compound 7j, 2-[2-(3,5-dimethoxy-phenyl)vinyl]thiophene, showed greater inhibitory activities but had a lower selectivity toward all of the CYP1s tested.
    DOI:
    10.1021/jm010298j
点击查看最新优质反应信息

文献信息

  • 3,5-Bis(trifluoromethyl)phenyl Sulfones in the Direct Julia−Kocienski Olefination
    作者:Diego A. Alonso、Mónica Fuensanta、Carmen Nájera、Montserrat Varea
    DOI:10.1021/jo050852n
    日期:2005.8.1
    sulfones, giving poorer results. Methylenation of aliphatic and aromatic aldehydes, ketones, and 1,2-dicarbonyl compounds is carried out through the modified Julia olefination using BTFP methyl sulfone 7d to give terminal alkenes and dienes. Mechanistic studies of the olefination reaction between benzyl BTFP sulfone 7a and aromatic aldehydes performed by KOH-induced Smiles rearrangement of stereodefined syn-
    3,5-双(三氟甲基)苯基(BTFP)砜7已用于与羰基化合物的Julia-Kocienski烯化反应中。砜7易于通过烷基化/氧化两步法从市售3,5-双(三氟甲基)苯硫酚中高产率(64-97%)制备。已经研究了金属化BTFP砜的稳定性并将其与杂芳基苯并噻唑-2-基(BT),1-苯基-1 H-四唑-5-基(PT)和1-叔丁基-1 H-四唑- -5-基(TBT)砜9 - 11不同的反应条件下。烷基BTFP砜之间的Julia-Kocienski烯烃7各种各样的醛以良好的收率和立体选择性提供相应的1,2-二取代的烯烃和二烯。可以在室温下使用KOH或在-78°C或室温下使用磷腈碱P2-Et和P4- t - Bu进行此一锅操作规程,已成功用于各种甲氧基化对苯二酚的高产率和立体选择性合成中如三甲基化白藜芦醇。Julia-Kocienski烯烃化反应的这些新反应条件也已用BT,PT和TBT砜进行了研究,但结果较差。脂族和芳族醛,酮和1
  • Anticancer Evaluation of 3,4,5,4'-trans-tetramethoxystilbene (DMU-212) and Its Analogs Against an Extensive Panel of Human Tumor Cell Lines
    作者:Nikhil Madadi、Peter Crooks
    DOI:10.2174/1570180812999150324163710
    日期:2015.6.6
    DMU-212, a methoxylated resveratrol analog, has significant anticancer activity, and selectively targets tumor cells. A library of E-diarylstilbenes structurally related to DMU-212 has been synthesized and evaluated for anticancer activity against a large panel of 45 human cancer cell lines. From this study, DMU-212 (3a) exhibited an average growth inhibitory effect (GI50) of 3.5 M against all the human cancer cell lines in the panel, and was particularly effective against the four cancer cell lines: SNB-75 (CNS), MDA-MB-435 (melanoma), A498 (renal), and MCF7 (breast), with GI50 values of 1.88, 1.04, 0.74 and 1.66 µM, respectively. Also, the 4’-chloro analog of DMU-212, 3d, exhibited 98 and 80 percent growth inhibition against MDA-MB-435 (melanoma) and K-562 (leukemia) cancer cell lines at a concentration of 10 M. Further investigation of DMU-212 and its analogs may provide novel therapeutic avenues for treatment of a variety of human cancers.
    DMU-212,一种甲氧基化的白藜芦醇类似物,具有显著的抗癌活性,并选择性地靶向肿瘤细胞。已经合成了一系列结构上与DMU-212相关的E-二芳烯烃,并评估其对45种人类癌细胞系的抗癌活性。在这项研究中,DMU-212 (3a) 对所有人类癌细胞系的平均生长抑制效果(GI50)为3.5 μM,对四种癌细胞系表现出特别有效的效果:SNB-75(中枢神经系统)、MDA-MB-435(黑色素瘤)、A498(肾脏)和MCF7(乳腺),其GI50值分别为1.88、1.04、0.74和1.66 μM。此外,DMU-212的4'-氯类似物3d在10 μM浓度下对MDA-MB-435(黑色素瘤)和K-562(白血病)癌细胞系表现出98%和80%的生长抑制。对DMU-212及其类似物的进一步研究可能为治疗各种人类癌症提供新颖的治疗途径。
  • Stilbene derivatives and their use in medicaments
    申请人:Szekeres Thomas
    公开号:US20070191627A1
    公开(公告)日:2007-08-16
    The invention relates to stilbene derivatives of general formula (I), in which at least four of the substituents R 1 to R 6 do not represent hydrogen. The substituents are effective radical captors, anti-tumour active ingredients and selective cyclooxygenase-2 inhibitors.
    该发明涉及一般式(I)的stilbene衍生物,其中至少有四个取代基R1至R6不代表氢。这些取代基是有效的自由基捕获剂、抗肿瘤活性成分和选择性环氧合酶-2抑制剂。
  • Solid-Phase Reactive Chromatography (SPRC): A New Methodology for Wittig and Horner–Emmons Reactions on a Column under Microwave Irradiation
    作者:Saada C. Dakdouki、Didier Villemin、Nathalie Bar
    DOI:10.1002/ejoc.200901032
    日期:2010.1
    A new methodology named solid-phase reactive chromatography (SPRC), which combines reaction, separation, and purification into a single unit for the preparation of small samples, is described. This method was illustrated in the synthesis of some natural bioactive compounds, namely, methoxylated analogues of resveratrol, alkylresorcinols, and 5-aryl-2,4-pentadienoates, over a column of alumina-KF under
    描述了一种名为固相反应色谱 (SPRC) 的新方法,它将反应、分离和纯化结合到一个单元中,用于制备小样品。这种方法在一些天然生物活性化合物的合成中得到了说明,即白藜芦醇、烷基间苯二酚和 5-芳基-2,4-戊二烯酸酯的甲氧基化类似物,在微波辐射下,使用 Wittig 和 Horner-在氧化铝-KF 柱上合成。埃蒙斯反应。这种方法允许在较短的反应时间内制备具有高纯度和良好至极好产率的目标烯烃。
  • Resveratrol analogs for prevention of disease
    申请人:——
    公开号:US20020028852A1
    公开(公告)日:2002-03-07
    Compositions and methods for prevention or treatment of disease are provided which comprise analogs of Resveratrol.
    提供了预防或治疗疾病的组合物和方法,其中包括白藜芦醇类似物。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸